This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy International Europe
3-5 November 2026
Berlin, Germany
Book Now
Menu
Book
Key Sessions
Keynote: Building a CAR-T Manufacturing Facility from a Greenfield to Operation
Panel Discussion: Strategies for Scaling Up, Accelerating and Commercialising Gene Therapy Manufacturing
keyboard_arrow_right

Monday 1st December – Day 1 Main Conference - GMT (Greenwich Mean Time, GMTZ)

keyboard_arrow_leftSearch & Filter
search
Monday 1st December – Day 1 Main Conference - GMT (Greenwich Mean Time, GMTZ)
search
Showing 1 of 1 Streams
11:10 - 11:15
Chairperson's Opening Remarks
11:15 - 11:45
Toward Profitable Implementation of Low Cost AAV Viral Vectors: Engineered HEK-293 Cells and New Manufacturing Tools Will Combine to Yield High-Productivity Producer Cells
11:45 - 12:15
Manufacturing Scale Upstream Process Evolution: From External Development to Internal Facility Establishment
12:15 - 12:45
Master the Upstream: Using Innovation and Know-How to Drive Gene Therapy Forward
Showing 1 of 1 Streams
14:00 - 14:30
Full Capsids Enrichment Polishing Benchmark
14:30 - 15:00
Applying Viral Vector Vaccine Learnings to Gene Therapy: To Expect the Unexpected
15:00 - 15:30
Orthogonal PAT Analytics - Essential to Enable Robust Production of Viral Vectors and LNPs
Showing 1 of 1 Streams
16:10 - 16:40
The Need for an Unbiased Assay to Detect and Quantify Replication Competent AAV in Clinical Vector Products
16:40 - 17:10
Panel Discussion: Strategies for Scaling Up, Accelerating and Commercialising Gene Therapy Manufacturing
NextTuesday 2nd December – Day 2 Main Conference
Filter
Streams
Clear
Topics
Choose Day